electroCore (ECOR) Projected to Post Earnings on Wednesday

electroCore (NASDAQ:ECOR) is projected to announce its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect electroCore to post earnings of ($0.59) per share and revenue of $9.0120 million for the quarter. Investors can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 4:30 PM ET.

electroCore (NASDAQ:ECOR) last issued its quarterly earnings results on Thursday, March 19th. The company reported ($0.34) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01. electroCore had a negative net margin of 43.60% and a negative return on equity of 1,956.38%. The business had revenue of $9.24 million during the quarter, compared to analyst estimates of $9.09 million. On average, analysts expect electroCore to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

electroCore Price Performance

ECOR stock opened at $6.68 on Tuesday. The company has a 50 day moving average price of $6.59 and a 200 day moving average price of $5.84. electroCore has a fifty-two week low of $4.16 and a fifty-two week high of $8.64. The stock has a market capitalization of $53.97 million, a PE ratio of -4.05 and a beta of 0.68.

Wall Street Analyst Weigh In

ECOR has been the subject of several research reports. HC Wainwright lowered their target price on electroCore from $25.00 to $18.00 and set a “buy” rating for the company in a research note on Monday, January 26th. upgraded electroCore to a “strong-buy” rating in a report on Tuesday, February 3rd. Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a research report on Friday, March 27th. Finally, Zacks Research raised electroCore from a “strong sell” rating to a “hold” rating in a report on Friday, March 27th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, electroCore presently has a consensus rating of “Hold” and a consensus price target of $18.00.

Insider Activity

In related news, Director Daniel S. Goldberger sold 16,072 shares of the company’s stock in a transaction on Friday, April 10th. The shares were sold at an average price of $6.02, for a total value of $96,753.44. Following the completion of the sale, the director owned 291,471 shares in the company, valued at $1,754,655.42. This represents a 5.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 13.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Two Sigma Investments LP increased its holdings in shares of electroCore by 20.8% in the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after acquiring an additional 4,231 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of electroCore during the 1st quarter valued at about $153,000. Jane Street Group LLC lifted its holdings in shares of electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock valued at $246,000 after purchasing an additional 19,599 shares in the last quarter. DRW Securities LLC acquired a new position in shares of electroCore in the 4th quarter valued at approximately $264,000. Finally, NewEdge Advisors LLC grew its position in shares of electroCore by 857.9% in the 1st quarter. NewEdge Advisors LLC now owns 161,955 shares of the company’s stock valued at $1,083,000 after purchasing an additional 145,047 shares during the period. 26.74% of the stock is owned by institutional investors and hedge funds.

electroCore Company Profile

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.